So lets look at absolute positive senario here.
1. SVR comes early and is exactly what we dreamed of and SP booms.
2. We get an awesome CEO off the back of this info who wants to ride the wave
3. The new awesome CEO convinces the FDA to let us start at cohort 4 for Hep B.
4. The moment that FDA approval comes in we get a multi-billion dollar partnership announcement.
Plausible?
Lets look at the possible Negatives.
1. Management have ruined this stock too much and the SP tanks
2. SVR is a failure at the end of the year, and its the reason why they canned the trial. (if so then they should be jailed)
3. FDA refuse to let us use any of TT-034 data and we start from scratch and slowly fade away into oblivion through lack of investor confidence for future capital raising.
Probable?
- Forums
- ASX - By Stock
- BLT
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts, page-50
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online